LifeMD, Inc. - Common Stock (NQ:LFMD)

2.740 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about LifeMD, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

LifeMD (LFMD) Q2 2026 Earnings Call Transcript ↗

August 12, 2026

Revenue met guidance but profitability targets missed amid strategic restructuring.

Via The Motley Fool

Topics Earnings

LifeMD Q2 Earnings Call Highlights ↗

August 05, 2026

LifeMD (NASDAQ:LFMD) reported second-quarter revenue of $47.3 million, within its prior guidance range, while posting an adjusted EBITDA loss of approximately $3.5 million as elevated customer...

Via MarketBeat

Topics Earnings

LifeMD (NASDAQ:LFMD) Shares Slide After Q2 Revenue and EPS Miss ↗

August 05, 2026

Via Chartmill

LifeMD (NASDAQ:LFMD) Q1 Beats Fails to Halt 13% After-Market Slide ↗

May 06, 2026

Via Chartmill

LifeMD (LFMD) Q1 2026 Earnings Transcript ↗

May 06, 2026

LifeMD (LFMD) Q1 2026 Earnings Transcript

Via The Motley Fool

LifeMD Inc (NASDAQ:LFMD) Stock Falls 13% After Q4 Revenue and Earnings Miss ↗

March 09, 2026

Via Chartmill

Gapping stocks in Monday's session ↗

March 16, 2026

Via Chartmill

Gapping stocks in Tuesday's session ↗

March 10, 2026

Via Chartmill

Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List ↗

January 05, 2026

The development comes as attention remains on Hims’ longer-term business expansion initiatives.

Via Stocktwits

KeyCorp Delivers Sobering Outlook for LifeMD, Slashing Price Target Amidst Operational Headwinds

November 20, 2025

KeyCorp, through its KeyBanc capital markets division, has issued a significantly more pessimistic forecast for LifeMD (NASDAQ: LFMD) stock, dramatically lowering its price objective to $8.00 from a...

Via MarketMinute

Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

November 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 18, 2025

Via Benzinga

Top movers in Tuesday's session ↗

November 18, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 18, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

November 18, 2025

Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Dow Falls Over 300 Points; Home Depot Posts Downbeat Earnings ↗

November 18, 2025

Via Benzinga

Topics Stocks

These stocks that are showing activity before the opening bell on Tuesday. ↗

November 18, 2025

As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Alphabet To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 18, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 18, 2025

Via Benzinga

Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗

November 18, 2025

Via Benzinga

LifeMD Inc (NASDAQ:LFMD) Stock Plummets Over 22% After Q3 2025 Earnings Miss ↗

November 17, 2025

LifeMD stock plunges after Q3 2025 earnings miss analyst estimates on both revenue and EPS, triggering a major sell-off.

Via Chartmill

Topics Earnings

What's going on in today's after hours session ↗

November 17, 2025

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

LifeMD Stock Plummets After Q3 Earnings: Here's Why ↗

November 17, 2025

Here's a look at the details from LifeMD's Q3 earnings report.

Via Benzinga

Novo Nordisk Leans Into Affordability Amid Rising Competition ↗

November 17, 2025

Novo Nordisk offers limited-time $199 pricing on Wegovy and Ozempic, lowers self-pay costs, and prepares for a stronger Wegovy pill rollout.

Via Benzinga

Earnings Scheduled For November 17, 2025 ↗

November 17, 2025

Via Benzinga

Examining the Future: LifeMD's Earnings Outlook ↗

November 14, 2025

Via Benzinga

Hims & Hers Health (HIMS) Surges After Hours on Robust Q3 and Renewed Novo Nordisk (NVO) Wegovy Talks

November 03, 2025

Hims & Hers Health (NYSE: HIMS) became a significant after-hours mover on Monday, November 3, 2025, following the release of its third-quarter 2025 financial results and the pivotal announcement of...

Via MarketMinute

Topics Artificial Intelligence Economy

LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm

October 27, 2025

From The Schall Law Firm

Via Business Wire

LFMD FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Investors of LifeMD Upcoming Lead Plaintiff Deadline on Monday, October 27, 2025

October 27, 2025

From Faruqi & Faruqi, LLP

Via Business Wire

LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm

October 27, 2025

From Schall Law

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.